跳至主要内容
临床试验/EUCTR2009-011173-32-GB
EUCTR2009-011173-32-GB进行中(未招募)不适用

Treating painful hand osteoarthritis using low dose oral prednisolone- assessing short-term pain and imaging outcomes - POLO

niversity of Leeds0 个研究点开始时间: 2009年5月29日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patients must fulfil the American College of Rheumatology criteria for OA of the small joints of the hand (see appendix B).
  • 2.Moderately severe symptoms (=40/100 on hand pain VAS at screening).
  • 3.Symptoms present on most days over the last 3 months.
  • 4.A previous radiograph of the hands with changes consistent with osteoarthritis.
  • 5.Stable analgesic requirements (including NSAIDs) for at least 4 weeks.
  • 6.Stable doses of chondroitin or glucosamine for 4 months.
  • 7.No oral, IM, IA, or IV steroids during the last 3 months.
  • 8.The patient must be able to adhere to the study visit schedule and other protocol requirements.
  • 9.The patient must be capable of giving informed consent and the consent must be obtained prior to any screening procedures
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.The presence of an inflammatory arthritis.
  • 2.Sensitivity, anaphylaxis or allergy to prednisolone.
  • 3.Patients who are pregnant, lactating or using hormonal birth control pills.
  • 4.Currently uncontrolled diabetes.
  • 5.Currently uncontrolled hypertension.
  • 6.Current active infection.
  • 7.Surgical procedure within 30 days of study initiation.
  • 8.Patients with osteoporosis or taking bisphosphonates.
  • 9.Patients will not be eligible if they have any contraindications to MRI scanning:
  • Pacemakers
  • Surgical clips within the head
  • Certain inner ear implants
  • Neuro-electrical stimulators
  • Metal fragments within the eye or head
  • Pregnant or breastfeeding women
  • 10.Use of any investigational (unlicensed) drug within 1 month prior to screening or within 5 half-lives of the investigational agent, whichever is longer.
  • 11.Subjects with any uncontrolled, unstable or severe medical condition, which in the opinion of the investigator makes them unsuitable for the study

研究者

发起方
niversity of Leeds

相似试验